Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence tha...
Gespeichert in:
Veröffentlicht in: | Diabetes technology & therapeutics 2021-10, Vol.23 (10), p.715-725 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 725 |
---|---|
container_issue | 10 |
container_start_page | 715 |
container_title | Diabetes technology & therapeutics |
container_volume | 23 |
creator | Aleppo, Grazia Parkin, Christopher G Carlson, Anders L Galindo, Rodolfo J Kruger, Davida F Levy, Carol J Umpierrez, Guillermo E Forlenza, Gregory P McGill, Janet B |
description | Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes. |
doi_str_mv | 10.1089/dia.2021.0196 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8573795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2579789941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</originalsourceid><addsrcrecordid>eNpdkUuPFCEUhYnROA9dujUkbtxUC0XRgAuTscdHJ21czLgmQN2aYVINI48xLv3nUulxoq64F76cew8HoReUrCiR6s3ozaonPV0RqtaP0DHlXHSSK_Z4qXvSKcrXR-gk5xtCiGA9fYqO2ECEWIvhGP3axVywD_gymZBnU3wMb_EZPvfZxRDAFfweyg-AgMs14AvnITjAJoz4C4zemQR4E-8gmatWJF8geYOnmNptKD7UWDO-qNbVYgIszTbkOreB2zDV3KY9Q08mM2d4fn-eom8fP1xuPne7r5-2m7Nd5wbKSzfIcRJ2IOM0GODSSuJgAGmkaJ2Q1hmraE_I2I9cAbNCykmRXhgyWcmMZafo3UH3tto9jA5CSWbWt8nvTfqpo_H635fgr_VVvNOSCyYUbwKv7wVS_F4hF71vnwTzfDCme87WklDGZENf_YfexJpCs9cooYRUaqCN6g6USzHnBNPDMpToJVzdwtVLuHoJt_Ev_3bwQP9Jk_0Gd5-iww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579789941</pqid></control><display><type>article</type><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</creator><creatorcontrib>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</creatorcontrib><description>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</description><identifier>ISSN: 1520-9156</identifier><identifier>EISSN: 1557-8593</identifier><identifier>DOI: 10.1089/dia.2021.0196</identifier><identifier>PMID: 34077674</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Aged ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Drug delivery systems ; Glucose monitoring ; Humans ; Hypoglycemic Agents - therapeutic use ; Insulin ; Insulin - therapeutic use ; Insulin Infusion Systems ; Insurance coverage ; Medicare ; Sensors ; United States</subject><ispartof>Diabetes technology & therapeutics, 2021-10, Vol.23 (10), p.715-725</ispartof><rights>Copyright Mary Ann Liebert, Inc. Oct 2021</rights><rights>Grazia Aleppo, et al., 2021; Published by Mary Ann Liebert, Inc. 2021 Grazia Aleppo, et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</citedby><cites>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</cites><orcidid>0000-0001-6838-5355 ; 0000-0002-9295-3225 ; 0000-0003-3607-9788 ; 0000-0002-6228-6521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34077674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aleppo, Grazia</creatorcontrib><creatorcontrib>Parkin, Christopher G</creatorcontrib><creatorcontrib>Carlson, Anders L</creatorcontrib><creatorcontrib>Galindo, Rodolfo J</creatorcontrib><creatorcontrib>Kruger, Davida F</creatorcontrib><creatorcontrib>Levy, Carol J</creatorcontrib><creatorcontrib>Umpierrez, Guillermo E</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>McGill, Janet B</creatorcontrib><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><title>Diabetes technology & therapeutics</title><addtitle>Diabetes Technol Ther</addtitle><description>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</description><subject>Aged</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Drug delivery systems</subject><subject>Glucose monitoring</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>Insulin Infusion Systems</subject><subject>Insurance coverage</subject><subject>Medicare</subject><subject>Sensors</subject><subject>United States</subject><issn>1520-9156</issn><issn>1557-8593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUuPFCEUhYnROA9dujUkbtxUC0XRgAuTscdHJ21czLgmQN2aYVINI48xLv3nUulxoq64F76cew8HoReUrCiR6s3ozaonPV0RqtaP0DHlXHSSK_Z4qXvSKcrXR-gk5xtCiGA9fYqO2ECEWIvhGP3axVywD_gymZBnU3wMb_EZPvfZxRDAFfweyg-AgMs14AvnITjAJoz4C4zemQR4E-8gmatWJF8geYOnmNptKD7UWDO-qNbVYgIszTbkOreB2zDV3KY9Q08mM2d4fn-eom8fP1xuPne7r5-2m7Nd5wbKSzfIcRJ2IOM0GODSSuJgAGmkaJ2Q1hmraE_I2I9cAbNCykmRXhgyWcmMZafo3UH3tto9jA5CSWbWt8nvTfqpo_H635fgr_VVvNOSCyYUbwKv7wVS_F4hF71vnwTzfDCme87WklDGZENf_YfexJpCs9cooYRUaqCN6g6USzHnBNPDMpToJVzdwtVLuHoJt_Ev_3bwQP9Jk_0Gd5-iww</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Aleppo, Grazia</creator><creator>Parkin, Christopher G</creator><creator>Carlson, Anders L</creator><creator>Galindo, Rodolfo J</creator><creator>Kruger, Davida F</creator><creator>Levy, Carol J</creator><creator>Umpierrez, Guillermo E</creator><creator>Forlenza, Gregory P</creator><creator>McGill, Janet B</creator><general>Mary Ann Liebert, Inc</general><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6838-5355</orcidid><orcidid>https://orcid.org/0000-0002-9295-3225</orcidid><orcidid>https://orcid.org/0000-0003-3607-9788</orcidid><orcidid>https://orcid.org/0000-0002-6228-6521</orcidid></search><sort><creationdate>20211001</creationdate><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><author>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Drug delivery systems</topic><topic>Glucose monitoring</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>Insulin Infusion Systems</topic><topic>Insurance coverage</topic><topic>Medicare</topic><topic>Sensors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aleppo, Grazia</creatorcontrib><creatorcontrib>Parkin, Christopher G</creatorcontrib><creatorcontrib>Carlson, Anders L</creatorcontrib><creatorcontrib>Galindo, Rodolfo J</creatorcontrib><creatorcontrib>Kruger, Davida F</creatorcontrib><creatorcontrib>Levy, Carol J</creatorcontrib><creatorcontrib>Umpierrez, Guillermo E</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>McGill, Janet B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes technology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aleppo, Grazia</au><au>Parkin, Christopher G</au><au>Carlson, Anders L</au><au>Galindo, Rodolfo J</au><au>Kruger, Davida F</au><au>Levy, Carol J</au><au>Umpierrez, Guillermo E</au><au>Forlenza, Gregory P</au><au>McGill, Janet B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</atitle><jtitle>Diabetes technology & therapeutics</jtitle><addtitle>Diabetes Technol Ther</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>23</volume><issue>10</issue><spage>715</spage><epage>725</epage><pages>715-725</pages><issn>1520-9156</issn><eissn>1557-8593</eissn><abstract>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>34077674</pmid><doi>10.1089/dia.2021.0196</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6838-5355</orcidid><orcidid>https://orcid.org/0000-0002-9295-3225</orcidid><orcidid>https://orcid.org/0000-0003-3607-9788</orcidid><orcidid>https://orcid.org/0000-0002-6228-6521</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1520-9156 |
ispartof | Diabetes technology & therapeutics, 2021-10, Vol.23 (10), p.715-725 |
issn | 1520-9156 1557-8593 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8573795 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Diabetes Diabetes Mellitus, Type 2 - drug therapy Drug delivery systems Glucose monitoring Humans Hypoglycemic Agents - therapeutic use Insulin Insulin - therapeutic use Insulin Infusion Systems Insurance coverage Medicare Sensors United States |
title | Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-17T00%3A27%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lost%20in%20Translation:%20A%20Disconnect%20Between%20the%20Science%20and%20Medicare%20Coverage%20Criteria%20for%20Continuous%20Subcutaneous%20Insulin%20Infusion&rft.jtitle=Diabetes%20technology%20&%20therapeutics&rft.au=Aleppo,%20Grazia&rft.date=2021-10-01&rft.volume=23&rft.issue=10&rft.spage=715&rft.epage=725&rft.pages=715-725&rft.issn=1520-9156&rft.eissn=1557-8593&rft_id=info:doi/10.1089/dia.2021.0196&rft_dat=%3Cproquest_pubme%3E2579789941%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579789941&rft_id=info:pmid/34077674&rfr_iscdi=true |